IPD impedimed limited

13.8%

3.3¢

Media, page-231

First 231 Last

Share
Profile

Follow
nottawombat

6,848 Posts.

763

08/07/24

11:19

Post #: 74651658
Share

Originally posted by DavidJJ: ↑

Today from ScoPo at *

Overlooked ImpediMed close to 24-month lows. Power says ImpediMed (ASX:IPD) is a stock worth watching with its share price drifting back close to 24-months lows and investors seemingly overlooking a number of positives, including a complete refresh of the board and new appointments to the management team. IPD is a world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The company’s SOZO device is the only FDA-cleared BIS solution for the clinical assessment of lymphoedema. “Our focus is on the growth of the US installed base (currently at 555 units), which since the technology has been included in the national guidelines in March 2023, has been below expectations,” Morgans says in a note to clients. “Under the new team, we are now expecting to see the start of consistent and meaningful growth in the installed base, which will be a key driver to moving the company to a break-even point within two years and improving investor sentiment. ”Power says Morgans’ view is that the new management has the business under control and costs are looking good. “The market is really looking for an increase in the installed base in the US,” he says. IPD is due to report its quarterly at the end of July. Morgans maintains a speculative buy recommendation on IPD with a 12-month price target of 20 cents.

Expand

the feedback I got from my broker ( interpretation from a call they did perhaps month or more ago ) was that the upcoming quarterly could be better than expected. But obviously coming from a low base

which clearly is not what the market thinks .. lol

IPD Price at posting: 6.7¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 231 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.3¢		Change 0.004(13.8%)		Mkt cap ! $66.90M

Open	High	Low	Value	Volume
3.0¢	3.3¢	2.9¢	$108.8K	3.507M

Buyers (Bids)

No.	Vol.	Price($)
1	50000	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	1063	1

View Market Depth

No.	Vol.	Price($)
1	50000	0.030
3	1445672	0.029
3	187894	0.028
5	635000	0.027
5	1619829	0.026

Price($)	Vol.	No.
0.033	1063	1
0.034	123000	1
0.035	335714	2
0.036	250000	1
0.037	100000	1

Last trade - 16.19pm 27/06/2025 (20 minute delay)

IPD (ASX) Chart

Media, page-231

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media, page-231

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News